These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8606734)

  • 61. Acute oliguric renal failure associated with angiotensin II receptor antagonists.
    Lee HY; Kim CH
    Am J Med; 2001 Aug; 111(2):162-3. PubMed ID: 11501548
    [No Abstract]   [Full Text] [Related]  

  • 62. Role of erythropoietin in pathogenesis of post transplant erythrocytosis (PTE) and mechanism of losartan's efficiency.
    Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
    Nephrol Dial Transplant; 1997 Mar; 12(3):626-7. PubMed ID: 9075166
    [No Abstract]   [Full Text] [Related]  

  • 63. [Angioedema due to irbesartan].
    Rodríguez Conesa A; Matilla Fernández B; Gozalo Reques F
    Rev Esp Cardiol; 2001 Apr; 54(4):532. PubMed ID: 11282063
    [No Abstract]   [Full Text] [Related]  

  • 64. Drug points: prolonged cholestasis associated with irbesartan.
    Hariraj R; Stoner E; Jader S; Preston DM
    BMJ; 2000 Sep; 321(7260):547. PubMed ID: 10968816
    [No Abstract]   [Full Text] [Related]  

  • 65. Chronic diarrhea and weight loss.
    Gaur V; Albeldawi M; Weber L
    Gastroenterology; 2014 Feb; 146(2):347,591. PubMed ID: 24342809
    [No Abstract]   [Full Text] [Related]  

  • 66. Renal glycosuria and azotemia after enalapril maleate (MK-421).
    Cressman MD; Vidt DG; Acker C
    Lancet; 1982 Aug; 2(8295):440. PubMed ID: 6124829
    [No Abstract]   [Full Text] [Related]  

  • 67. Conversion from migraine without aura to typical aura without headache after irbesartan.
    Pinessi L; Ferrero M; Gentile S; Rainero I
    J Headache Pain; 2005 Apr; 6(2):100. PubMed ID: 16362652
    [No Abstract]   [Full Text] [Related]  

  • 68. Toxic hepatitis due to enalapril in childhood.
    Baş V; Erkan T; Calişkan S; Sever L; Kasapçopur O; Ozbay G; ArIsoy N
    Pediatr Int; 2003 Dec; 45(6):755-7. PubMed ID: 14651558
    [No Abstract]   [Full Text] [Related]  

  • 69. Basophil activation in two cases of hydrochlorothiazide-induced noncardiogenic pulmonary edema.
    Manso L; Heili S; Fernández-Nieto M; Sastre B; Sastre J
    Allergy; 2010 Jan; 65(1):135-6. PubMed ID: 19804446
    [No Abstract]   [Full Text] [Related]  

  • 70. Olmesartan induced enterocolitis.
    Gallivan C; Brown I
    Pathology; 2014 Jun; 46(4):360-1. PubMed ID: 24798161
    [No Abstract]   [Full Text] [Related]  

  • 71. Autoimmune-like chronic hepatitis induced by olmesartan.
    Barge S; Ziol M; Nault JC
    Hepatology; 2017 Dec; 66(6):2086-2088. PubMed ID: 28437842
    [No Abstract]   [Full Text] [Related]  

  • 72. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
    Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
    Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
    [No Abstract]   [Full Text] [Related]  

  • 73. Drug-induced small-bowel mucosal atrophy.
    Santos-Antunes J; Coelho R; Cardoso H; Macedo G
    Endoscopy; 2015; 47 Suppl 1 UCTN():E8. PubMed ID: 25603525
    [No Abstract]   [Full Text] [Related]  

  • 74. Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation.
    Simonetti GD; Bianchetti MG; Konrad M; von Vigier RO
    Pediatr Nephrol; 2007 May; 22(5):756-7. PubMed ID: 17216246
    [No Abstract]   [Full Text] [Related]  

  • 75. The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan.
    Camelo Castillo W; Delaney JA; Stürmer T
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):357-60. PubMed ID: 24590633
    [No Abstract]   [Full Text] [Related]  

  • 76. Olmesartan-induced enteropathy resembling celiac disease.
    Khan AS; Peter S; Wilcox CM
    Endoscopy; 2014; 46 Suppl 1 UCTN():E97-8. PubMed ID: 24676835
    [No Abstract]   [Full Text] [Related]  

  • 77. [Sprue-like enteropathy in the elderly treated with olmesartan].
    Calvo Beguería E; Martinez Huguet C; Gonzalez García MP; Omiste SanVicente T
    Rev Esp Geriatr Gerontol; 2017; 52(4):223-224. PubMed ID: 28277303
    [No Abstract]   [Full Text] [Related]  

  • 78. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
    Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
    Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
    [No Abstract]   [Full Text] [Related]  

  • 79. Two coincident cases of easily curable 'refractory sprue'.
    Schiller D; Ziachehabi A; Silye R; Schöfl R
    Gut; 2015 Nov; 64(11):1714, 1773. PubMed ID: 25717152
    [No Abstract]   [Full Text] [Related]  

  • 80. Gastrointestinal: Olmesartan-induced enteropathy.
    Shahzad MA; Harding D; Ruszkiewicz A; Tran E; England G; Philpott H
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1691. PubMed ID: 29968297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.